The role of astrocyte dysfunction in Parkinson's disease pathogenesis ‌ Booth, H, Hirst, W, Wade-Martins, R

Induction of tumour rejection by autologous and allogeneic tumour cells expressing B7.1 and IL-2. ‌ Hirst, W, Darling, D, Gaken, J, Buggins, A, Barnard, A, GaleaLauri, J, Kuiper, M, Hollignsworth, S, Mufti, G, Farzaneh, F

Induction of tumour rejection by B7.1 and IL-2 expressing tumour cells ‌ Gaken, J, Hirst, W, Darling, D, GaleaLauri, J, Buggins, A, Kuiper, M, Souberbielle, B, Towner, P, Hollingsworth, S, Mufti, G, Farzaneh, F

In vitro immune modulation by antibodies coupled to tumour cells. ‌ Darling, D, Galea-Lauri, J, Gäken, J, Towner, P, Kuiper, M, Hollingsworth, S, Hirst, W, Barnard, A, Buggins, A, Mufti, G, Farzaneh, F

Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors. ‌ Gaken, J, Hollingsworth, S, Hirst, W, Buggins, A, Galea-Lauri, J, Peakman, M, Kuiper, M, Patel, P, Towner, P, Patel, P, Collins, M, Mufti, G, Farzaneh, F, Darling, D

An integrated transcriptomics and proteomics analysis reveals functional endocytic dysregulation caused by mutations in LRRK2 ‌ Connor-Robson, N, Booth, H, Martin, JG, Gao, B, Li, K, Doig, N, Vowles, J, Browne, C, Klinger, L, Juhasz, P, Klein, C, Cowley, SA, Bolam, P, Hirst, W, Wade-Martins, R